A Phase 2 Trial of Flavopiridol (Alvocidib) and Cisplatin in Platin-Resistant Ovarian and Primary Peritoneal Carcinoma: MC0261
Bible, Keith C, Peethambaram, Prema P, Oberg, Ann L, Maples, William, Groteluschen, David L, Boente, Matthew, Burton, Jill K, Gomez Dahl, Leigh C, Tibodeau, Jennifer D, Isham, Crescent R, Maguire, Jacie L, Shridhar, Viji, Kukla, Andrea K, Voll, Kalli J, Mauer, Mathew J, Colevas, Alexander D, Wright, John, Doyle, L. Austin, Erlichman, Charles
Published in Gynecologic oncology (01.10.2012)
Published in Gynecologic oncology (01.10.2012)
Get full text
Journal Article
Abstract 4712: Evidence of clinical efficacy of the combination of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: Phase 2 trial MC0261
Bible, Keith Christopher, Peethambaram, Prema P., Oberg, Ann L., Maples, William J., Groteluschen, David L., Boente, Matthew, Burton, Jill K., Gomez-Dahl, Leigh C., Tibodeau, Jennifer D., Isham, Crescent R., Kukla, Andrea K., Voll, Kalli J., Colevas, Alexander D., Wright, John, Doyle, L Austin, Erlichman, Charles, Consortium, Mayo Phase
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article